Braun N, Lin C, Baker N, Peacker BL, et al. Glucagon-like peptide-1 receptor agonists mitigate the risk of major adverse cardiovascular events in patients with atopic dermatitis and type 2 diabetes. J Am Acad Dermatol 2025 Aug 18:S0190-9622(25)02645.
PMID: 40835131